Clyde’s characterisation
and validation service

For new hiPSC cardiomyocyte providers, Clyde can offer the following characterisation and validation service

  • Optimising plating densities lines

  • Assess voltage, calcium and contractility baseline characteristics

  • Perform restitution curve

  • Test CiPA 8 reference compounds

  • Test CiPA 28 reference compounds

  • Run head to head comparison with leading hiPSC cardiomyocyte provider

  • Characterise diseased hiPSC cardiomyocyte cell lines

The characterisation will provide the client with a comprehensive data package for marketing collateral. More importantly, the data will validate the cardiomyocyte for inclusion into the CiPA assay for IND submissions.


Start a study with Clyde

To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at